期刊文献+

APE1通过NF-κB通路调节结直肠癌PD-L1表达和细胞增殖 被引量:4

APE1 Inhibits Colorectal Cancer Proliferation through Inhibition of PD-L1 and Regulation of NF-κB Signaling Pathway
下载PDF
导出
摘要 目的探讨脱嘌呤/脱嘧啶核酸内切酶1(apurinic/aprimidinic endonuclease1,APE1)对结直肠癌组织及细胞程序性死亡配体-1(PD-L1)表达和细胞增殖的影响及其信号通路。方法收集67例结直肠癌及配对的癌旁组织,免疫组织化学染色检测组织APE1和PD-L1表达,分析APE1表达与结直肠癌患者临床资料的关系,并绘制不同APE1表达水平结直肠癌患者的生存曲线。利用siRNA技术沉默结直肠癌HT29、Ls174t中APE1表达,分别利用CCK-8和平板细胞克隆形成实验检测细胞增殖情况,蛋白质印迹法检测HT29、Ls174t细胞NF-κB信号通路相关蛋白表达。结果结直肠癌组织APE1、PD-L1阳性染色评分均明显高于癌旁组织,HT29、Ls174t细胞APE1、PD-L1蛋白相对表达量也明显高于结直肠上皮细胞HCEpi,差异具有统计学意义(均P<0.01)。相关性分析显示,结直肠癌组织APE1与PD-L1表达呈显著正相关(P<0.01)。APE1高表达与肿瘤直径(P=0.002)和病理学N分期(P=0.014)有关;APE1高表达组5年总生存率和无病生存率分别为49.7%和37.1%,明显低于APE1低表达组(75.1%和63.2%),差异均具有统计学意义(均P<0.05)。转染APE1 siRNA能下调HT29、Ls174t细胞APE1表达并导致PD-L1表达下调,肿瘤细胞增殖率和克隆形成数也明显降低(P<0.05,P<0.01)。同时,转染APE1 siRNA的HT29、Ls174t细胞磷酸化NF-κB表达水平明显低于NC-siRNA组和空白对照组(均P<0.01)。结论结直肠癌组织和细胞APE1、PD-L1表达上调,抑制APE1可能通过下调磷酸化NF-κB表达影响结直肠癌细胞的增殖。 Objective To investigate the effect of apurinic/aprimidinic endonuclease1(APE1)on the PD-L1 expression and proliferation in colorectal cancer cells and signal pathway mediated by it.Methods A total of 67 cases of colorectal cancer tissues and paired adenocarcinoma tissues were collected.The expression levels of APE1 and PD-L1 were measured by immunohistochemistry.Correlation between APE1 expression and colorectal cancer clinicopathologic features was also analyzed,survival curves were described by Kaplan-Meier method.Human colorectal cancer cell lines HT29 and Ls174 t were interfered with siRNAs for silencing APE1 expression.Cell proliferation was determined by CCK-8 assay and colony formation assay,respectively.The expression protein related to NF-κB pathway was detected by Western blotting.Results The staining scores of APE1 and PD-L1 were significantly higher in colorectal cancer tissues than in adenocarcinoma tissues.Besides,the expression of APE1 protein was significantly up-regulated in CRC cell lines HT29,Ls174 t compared with colorectal epithelial cells HCEpi(P<0.01).Correlation analysis showed that there was positive correlation between APE1 and PD-L1 expression in colorectal cancer tissues(P<0.01).APE1 expression level was strongly correlated with the tumor size(P=0.002)and N classification(P=0.014)in this cohort of 67 cases of CRC.Kaplan-Meier survival analysis confirmed that patients with high APE1 levels had poorer overall survival(P=0.020)and disease-free survival(P=0.029)than patients with low APE1 levels.APE1 siRNA effectively inhibited the expression of APE1 and PD-L1,which decreased the rates of cell apoptosis and colony number in HT29,Ls174 t cells(P<0.05).Meanwhile,in cells tranfected with APE1 siRNA,NF-κB phosphorylation expression was also inhibited when compared to the NC-siRNA group and blank control group(P<0.01).Conclusion APE1 and PD-L1 is up-regulated in colorectal cancer tissues and cells,down-regulation of APE1 is able to inhibit the proliferation of human CRC via the inhibition of NF-κB phosphorylation.
作者 吉祖进 张志云 高燕 雷新益 Ji Zujin;Zhang Zhiyun;Gao Yan(Department of Colorectal and Anal Surgery,Sinopharm Dongfeng General Hospital,Shiyan 442008,China;PET Center,Shiyan Taihe Hospital Affiliated Hospital of Hubei University of Medicine,Shiyan 442008,China)
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2019年第4期393-399,共7页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 2018年度十堰市市级引导性科研项目(No.18Y20)
关键词 结直肠癌 脱嘌呤/脱嘧啶核酸内切酶1 程序性死亡配体-1 细胞增殖 colorectal cancer apurinic/aprimidinic endonuclease 1 programmed death ligand-1 cellular proliferation
  • 相关文献

参考文献4

二级参考文献24

  • 1李连弟,陈育德.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社.2008.
  • 2陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 3赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 4Kelsen DP.胃肠肿瘤学:原理与实践[M].2版.梁寒,译.天津:天津科技翻译出版有限公司,2012.
  • 5Soerjomataram I, Lortct-Tieulent J, Parkin MD, et al. Global burden of cancer in 2008: a systematic analysis of disability- adjusted life-years in 12 world regions [J]. Lancet, 2012, 380 (9856) : 1840-1850.
  • 6Ferlay J, Socrjomatamm I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer [EB/OL]. (2013-12-12) [2014-09-01]. http:// globocan.iarc.fr.
  • 7Brenner H, Kloor M, Pox CP. Colorectal cancer[J]. Lancet, 2014,383(9927) : 1490-1502.
  • 8全国肿瘤防治研究办公室.中国恶性肿瘤死亡率调查研究(1973-1975)[M].北京:人民卫生出版社,1979.
  • 9赵平,孔灵芝.中国肿瘤死亡报告[R].北京:人民卫生出版社,2010.
  • 10Waterhouse J, Muir CS, Shanmugaratnam, K, et al. Cancer incidence in five continents. IARC scientific publications [M]. Lyon: International Agency for Research on Cancer, 1982.

共引文献194

同被引文献19

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部